pirenzepine has been researched along with Cancer of Pituitary in 2 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, C | 1 |
| Yamane, Y | 1 |
| Ishizuka, T | 1 |
| Kijima, H | 1 |
| Takano, K | 1 |
| Takano, A | 1 |
| Kubo, M | 1 |
| Koike, T | 1 |
| Akiyama, K | 1 |
| Vickroy, TW | 1 |
| Watson, M | 1 |
| Roeske, WR | 1 |
| Reisine, TD | 1 |
| Smith, TL | 1 |
| Yamamura, HI | 1 |
2 other studies available for pirenzepine and Cancer of Pituitary
| Article | Year |
|---|---|
Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenocorticotropic Hormone; Atropine; Choline; | 2001 |
Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover.
Topics: Adenylyl Cyclase Inhibitors; Animals; Atropine; Benzodiazepinones; Carbachol; Cells, Cultured; Cycli | 1986 |